NASDAQ:FBLG - Nasdaq - US31573L1052 - Common Stock - Currency: USD
1.22
+0.1 (+8.93%)
The current stock price of FBLG is 1.22 USD. In the past month the price decreased by -23.75%. In the past year, price decreased by -88.53%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 21.17 | 378.30B | ||
AMGN | AMGEN INC | 16.39 | 174.51B | ||
GILD | GILEAD SCIENCES INC | 25.47 | 146.22B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 1683.76 | 125.39B | ||
REGN | REGENERON PHARMACEUTICALS | 15.5 | 77.34B | ||
ARGX | ARGENX SE - ADR | 231.21 | 36.10B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 31.66B | ||
ONC | BEIGENE LTD-ADR | N/A | 26.47B | ||
BNTX | BIONTECH SE-ADR | N/A | 26.08B | ||
BIIB | BIOGEN INC | 9.13 | 22.01B | ||
NTRA | NATERA INC | N/A | 19.02B | ||
GMAB | GENMAB A/S -SP ADR | 24.89 | 15.34B |
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. The company is headquartered in Houston, Texas and currently employs 10 full-time employees. The company went IPO on 2024-01-31. The firm operates as a biopharmaceutical company. The company is focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. The company also develops biologic cures and treatments for chronic diseases, including degenerative disc disease, multiple sclerosis, wound healing, and cancer, and anti-aging extension of life applications such as thymic involution reversal and splenic involution reversal.
FIBROBIOLOGICS INC
455 E. Medical Center Blvd, Suite 300
Houston TEXAS US
Employees: 10
Company Website: https://fibrobiologics.com/
Investor Relations: http://ir.fibrobiologics.com/sec-filings/all-sec-filings
Phone: 12816715150
The current stock price of FBLG is 1.22 USD. The price increased by 8.93% in the last trading session.
The exchange symbol of FIBROBIOLOGICS INC is FBLG and it is listed on the Nasdaq exchange.
FBLG stock is listed on the Nasdaq exchange.
9 analysts have analysed FBLG and the average price target is 13.01 USD. This implies a price increase of 965.98% is expected in the next year compared to the current price of 1.22. Check the FIBROBIOLOGICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
FIBROBIOLOGICS INC (FBLG) has a market capitalization of 42.94M USD. This makes FBLG a Nano Cap stock.
FIBROBIOLOGICS INC (FBLG) currently has 10 employees.
FIBROBIOLOGICS INC (FBLG) has a support level at 1.12 and a resistance level at 1.27. Check the full technical report for a detailed analysis of FBLG support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
FBLG does not pay a dividend.
FIBROBIOLOGICS INC (FBLG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.89).
The outstanding short interest for FIBROBIOLOGICS INC (FBLG) is 7.21% of its float. Check the ownership tab for more information on the FBLG short interest.
ChartMill assigns a fundamental rating of 1 / 10 to FBLG. Both the profitability and financial health of FBLG have multiple concerns.
Over the last trailing twelve months FBLG reported a non-GAAP Earnings per Share(EPS) of -0.89. The EPS decreased by -321.94% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -169.83% | ||
ROE | -649.58% | ||
Debt/Equity | 0.04 |
ChartMill assigns a Buy % Consensus number of 82% to FBLG. The Buy consensus is the average rating of analysts ratings from 9 analysts.